Showing results (1781-1790 of 2,327) with videos related to

Sort By:
Pageof 233
Human Pathology|February 1, 1995
Human acute tubular necrosis: a lectin and immunohistochemical studyT Nadasdy, Z Laszik, K E Blick, et al.
Cancer Research|October 1, 1979
Phase I trial of N-(phosphonacetyl)-L-aspartateC Erlichman, J M Strong, P H Wiernik, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 1, 1991
Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fosT Kooistra, P J Bosma, K Toet, et al.
Molecular Psychiatry|September 18, 2013
Neural mechanisms underlying stress resilience in Ahi1 knockout mice: relevance to neuropsychiatric disordersA Lotan, T Lifschytz, A Slonimsky, et al.
Molecular and Cellular Biology|June 1, 1989
Use of a glucocorticoid-inducible promoter for expression of herpes simplex virus type 1 glycoprotein gC1, a cytotoxic protein in mammalian cellsH M Friedman, A Yee, H Diggelmann, et al.
Neurobiology of Aging|February 11, 2015
Alzheimer's disease is associated with low density of the long CR1 isoformRachid Mahmoudi, Aymric Kisserli, Jean-Luc Novella, et al.
Diagnostic Microbiology and Infectious Disease|June 6, 2024
Utility of microbial cell free DNA next-generation sequencing for diagnosis and management of infectious diseasesRiley Aiden-Croix Thompson, Monica A Donnelley, Kate Trigg, et al.
BMC Psychiatry|June 13, 2023
Neuro-psychiatric symptoms in directly and indirectly blast exposed civilian survivors of urban missile attacksR Saar-Ashkenazy, S Naparstek, Y Dizitzer, et al.
Developments in Biological Standardization|January 1, 1981
Theoretical and practical considerations in the application of killed poliovirus vaccine for the control of paralytic poliomyelitisJ Salk, A L van Wezel, P Stoeckel, et al.
Journal of Thrombosis and Haemostasis : JTH|August 20, 2016
Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolismD R J Arachchillage, I J Mackie, M Efthymiou, et al.
Pageof 233